STOCK TITAN

The Sherwin-Williams Company (SHW) Form 4 Filings

SHW NYSE

Here are the Form 4 insider transactions from The Sherwin-Williams Company (SHW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SHW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHW filings page.

Rhea-AI Summary

On November 4, 2026, James P. Lang, Sherwin-Williams’ SVP - Enterprise Finance & CAO, exercised options covering 620 shares at $295.83 and 689 shares at $193.35, then sold the corresponding shares. He sold 620 shares at a weighted average of $362.03 (trade prices ranged from $361.950 to $362.065) and 689 shares at $361.80. No Rule 10b5-1 plan is reported. A separate indirect holding lists 1,144.13 shares attributable to his participation in the 401(k) Plan per the trustee’s September 30, 2026 statement.

Rhea-AI Summary

Sherwin-Williams (SHW) SVP - Corp Strategy & Devel. Bryan J. Young exercised 1,314 options on November 3, 2026, at a $127.98 per-share exercise price, acquiring 1,314 common shares and selling 1,314 shares that day at $345.71 per share. His reported employee stock option position after the exercise was 7,446 options. A separate indirect 401(k) Plan holding was 566.44 shares, per the trustee's September 30, 2026 statement. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Sherwin-Williams SVP - IR & Corp. Comm. James R. Jaye exercised 4,527 employee stock options on November 3, 2026, at an exercise price of $134.63, acquiring 4,527 common shares. The reported option balance after the exercise was 0. He delivered or withheld 869 common shares for payment of exercise price or tax liability, recorded in two entries of 831 and 38 shares, and sold 2,301 shares at a weighted average price of $345.56. The sale prices ranged from $345.500 to $345.795. His indirect 401(k) Plan holding was 169.15 shares per the trustee's September 30, 2026 statement. The options were granted February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries, subject to vesting conditions.

Rhea-AI Summary

Sherwin-Williams (SHW) reported that Mary L. Garceau, SVP - CLO and Secretary, sold 3,891 shares of common stock on November 2, 2026, at a weighted-average price of $350.4200 per share. After the sale, she directly held 31,466 shares. A separate 401(k) Plan entry reports 961.71 shares attributable to her participation, based on the trustee's September 30, 2026 statement. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Sherwin-Williams Co. (SHW) reported that Bryan J. Young, SVP - Corp Strategy & Devel., received an award of 3,500 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

Rhea-AI Summary

Sherwin-Williams (SHW) President, Consumer Brands Grp Todd D. Rea received a direct grant of 4,470 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions, under the 2025 Equity and Incentive Compensation Plan.

Rhea-AI Summary

Sherwin-Williams President and CEO Heidi G. Petz received 47,640 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share and are exercisable for 47,640 shares of common stock. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions, and expire October 19, 2036.

Rhea-AI Summary

Sherwin-Williams (SHW) CFO and SVP - Finance Benjamin E. Meisenzahl received a direct grant of 13,805 employee stock options on October 20, 2026, under the 2025 Equity and Incentive Compensation Plan. The options have an exercise price of $335.04 per share and vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

Rhea-AI Summary

Sherwin Williams Co. (SHW) reported that James P. Lang, SVP - Enterprise Finance & CAO, received a direct grant of 2,335 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

Rhea-AI Summary

Sherwin-Williams Co. (SHW) reported that Karl J. Jorgenrud, President, Glob. Industrial, was granted 12,055 employee stock options on October 20, 2026, under the 2025 Equity and Incentive Compensation Plan. The options have an exercise price of $335.04 per share and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Sherwin-Williams Co. reported that SVP - IR & Corp. Comm. James R. Jaye acquired 2,335 employee stock options on October 20, 2026, to buy Common Stock at an exercise price of $335.04 per share. The options cover 2,335 shares, and his reported directly held position after the grant was 2,335 options. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions, and expire October 19, 2036.

Rhea-AI Summary

Sherwin-Williams (SHW) granted Mary L. Garceau, SVP - CLO and Secretary, 7,585 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

Rhea-AI Summary

Sherwin Williams Co. officer Colin M. Davie, Pres. & GM, Glob. Supply Chain, received a grant of 7,000 employee stock options on October 20, 2026, covering 7,000 shares of common stock. The options have a $335.04 exercise price and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions; the reported post-grant option position was 7,000.

Rhea-AI Summary

Sherwin Williams Co. (SHW) reported that SVP - CHRO Marlena K. Boyce received a grant of 6,220 employee stock options on October 20, 2026, with an exercise price of $335.04 per share. The options are for common stock, expire October 19, 2036, and were granted under the 2025 Equity and Incentive Compensation Plan.

Rhea-AI Summary

Sherwin-Williams (SHW) President, Glob. Architectural Justin T. Binns received a grant of 12,055 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share, expire October 19, 2036, and were granted under the 2025 Equity and Incentive Compensation Plan.

Rhea-AI Summary

Sherwin-Williams Co. (SHW) director Thomas Williams acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The transaction-date weighted average share price of $324.14 was used to determine the number of units credited. The Deferred Fee Plan position after the acquisition was 1,369.35 deferred stock units, including units acquired through the plan’s dividend reinvestment feature. A separate line for previously reported direct holdings lists 1,100 restricted stock units and 1,271 common shares.

Rhea-AI Summary

Sherwin Williams Co. (SHW) director Michael H. Thaman acquired 104.12 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted average share price was used to determine the number of units credited. The units are economically equivalent to common shares and payable solely in stock, generally after his separation from service as a director. No Rule 10b5-1 plan is reported. His indirect deferred stock unit holdings afterward were 5,830.87 units. A separate previously reported direct holding line lists 1,100 restricted stock units and 7,011 common shares.

Rhea-AI Summary

Sherwin-Williams director Robert James Gamgort acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The units are the economic equivalent of common shares and are payable solely in stock, generally following his separation from service as a director. His reported indirect deferred-unit balance after the acquisition was 691.12. A separate, previously reported direct holding comprised 1,075 securities: 902 restricted stock units and 173 common shares.

Rhea-AI Summary

Sherwin-Williams (SHW) director Kerrii B. Anderson acquired 30.85 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted-average share price was used to determine the number of units credited. The units are payable solely in stock, generally following her separation from service as a director; her reported deferred-unit balance afterward was 1,109.95. No Rule 10b5-1 plan is reported. A separate, previously reported holding entry lists 5,819 securities: 1,100 restricted stock units and 4,719 common shares.

Rhea-AI Summary

SHERWIN WILLIAMS CO (SHW) executive Justin T. Binns, President, Glob. Architectural, reported multiple transactions in Sherwin-Williams common stock. On August 17, 2026, he exercised 13,500 stock options with a $90.04 exercise price, receiving an equal number of common shares, and on the same date sold 13,500 shares at a weighted average price of about $352.70 per share in multiple trades between $353.01 and $352.66.

On August 18, 2026, he made a bona fide gift of 813 shares to a charitable donor advised fund. Following these transactions, 6,009.63 shares of common stock are attributable to his participation in The Sherwin-Williams Company 401(k) Plan, reported as indirect ownership. The exercised options, granted in 2016, are now fully exhausted according to this report.

Rhea-AI Summary

Sherwin-Williams Company officer Karl J. Jorgenrud, President, Global Industrial, reported several equity transactions on 2026-08-07. He exercised 90 stock options at an exercise price of $127.98 per share, receiving 90 shares of common stock. On the same date, he sold 7,886 shares of Sherwin-Williams common stock at $368.30 per share in a sale transaction. Following the option exercise, he held 4,260 employee stock options directly, expiring 2027-10-17, and had 1,252.54 shares of common stock attributable to his participation in The Sherwin-Williams Company 401(k) Plan as of 2026-06-30. The transactions are not indicated as being made pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Sherwin-Williams director Thomas Williams reported a compensation-related equity award rather than an open-market trade. He acquired 96.32 deferred stock units of common stock at a weighted average reference price of $350.40 per unit under the 2005 Director Deferred Fee Plan, in an exempt transaction. These units are economically equivalent to common shares and will generally be paid in stock after he leaves the board.

Following this award, Williams now indirectly holds 1,262.09 deferred stock units under the Deferred Fee Plan. Separately, he directly holds 2,371 common-stock-related interests, consisting of 1,334 restricted stock units and 1,037 shares of common stock, reflecting his ongoing equity-based stake in the company.

Rhea-AI Summary

The Sherwin-Williams Company director Michael H. Thaman acquired 96.32 deferred stock units of common stock on July 6, 2026 at a weighted average price of $350.40 per share under the 2005 Director Deferred Fee Plan. Each deferred stock unit is the economic equivalent of one share of common stock and will be paid solely in stock, generally after he leaves the board. Following this grant, he holds 5,712.57 deferred stock units indirectly through the plan and 8,111 equity interests directly, consisting of 1,100 restricted stock units and 7,011 shares of common stock.

Rhea-AI Summary

Sherwin-Williams director Robert James Gamgort reported a compensation-related stock award. He acquired 96.32 deferred stock units of common stock on July 6, 2026 in an exempt transaction under the company’s 2005 Director Deferred Fee Plan, at a weighted average price of $350.40 per unit.

Each deferred stock unit is economically equivalent to one share of common stock and will be settled in stock, generally after he leaves the board. Following this award, his Deferred Fee Plan account holds 585.55 deferred stock units held indirectly, while a separate line reflects 1,075 directly held shares previously reported.

Rhea-AI Summary

Sherwin-Williams director Kerrii B. Anderson received an award of deferred stock units under the company’s 2005 Director Deferred Fee Plan. She acquired 28.54 deferred stock units, each economically equivalent to one share of common stock, based on a weighted average share price of $350.40.

These units are held indirectly through the Deferred Fee Plan and become payable in stock, generally after she leaves the board. Following this award, she holds 1,076.42 deferred stock units under the plan, and separately has 5,819 direct equity interests, consisting of 1,100 restricted stock units and 4,719 common shares.

Rhea-AI Summary

Williams Thomas reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Thomas Williams received an award of 106.970 deferred stock units of common stock on April 6, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The weighted average share price used to determine this grant was $315.50 per share.

Each deferred stock unit is economically equivalent to one share of common stock and will be paid solely in stock, generally after he leaves the board. Following this grant, he indirectly holds 1,162.730 deferred stock units under the plan and, in a separate direct position, 2,371.000 common stock-related securities, including 1,334 restricted stock units and 1,037 shares.

Rhea-AI Summary

Sherwin-Williams director Michael H. Thaman received an equity-based compensation award in the form of deferred stock units tied to the company’s common stock. On the transaction date, he acquired 106.97 deferred stock units under the 2005 Director Deferred Fee Plan at a weighted average price reference of $315.50 per unit.

Each deferred stock unit is economically equivalent to one share of common stock and will be settled in stock, generally after he leaves the board. Following this grant, he indirectly holds 5,601.56 deferred stock units in the Deferred Fee Plan and directly holds 8,111 common-related units, consisting of 1,100 restricted stock units and 7,011 shares of common stock. No open-market purchases or sales were reported, and no derivative securities remain outstanding in this filing.

Rhea-AI Summary

SHERWIN WILLIAMS CO director Robert James Gamgort acquired 106.97 deferred stock units of common stock in an exempt award under the company’s 2005 Director Deferred Fee Plan. Each deferred stock unit is economically equivalent to one common share and is generally payable in stock after he leaves the board.

Following this grant, he indirectly holds 487.96 deferred stock units under the Deferred Fee Plan and continues to hold 1,075 restricted stock units directly, each representing the right to receive one common share. No open‑market purchases or sales were reported in this filing.

Rhea-AI Summary

ANDERSON KERRII B reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Kerrii B. Anderson received a grant of deferred stock units tied to company common stock as part of director compensation. On this date, 31.7 deferred stock units were credited to her account under the 2005 Director Deferred Fee Plan, using a weighted average price of $315.50 per share to determine the number of units.

Each deferred stock unit is economically equivalent to one share of common stock and will be paid solely in stock, generally after she leaves the board. Following this grant, she holds 1,045.15 deferred stock units indirectly under the Deferred Fee Plan and 5,819 common share-related interests directly, consisting of 1,100 restricted stock units and 4,719 shares of common stock.

Rhea-AI Summary

Sherwin-Williams Company senior vice president Bryan J. Young reported an open-market sale of Common Stock. On February 24, 2026, he sold 2,513 shares at an average price of $364.47 per share. After this sale, he directly held 10,045 shares and had 519 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan, based on the trustee’s February 13, 2026 statement.

Rhea-AI Summary

The Sherwin-Williams Company senior vice president Bryan J. Young reported equity compensation activity involving the company’s common stock. He acquired 3,900 shares through the vesting and payout of a performance-based restricted stock unit award granted on February 14, 2023 for the 2023–2025 performance period.

To cover tax withholding obligations from this vesting, 1,387 shares were mandatorily withheld by the company at a price of $368.59 per share, a tax-withholding disposition rather than an open-market sale. Following these transactions, Young directly owned 12,558 shares, and an additional 519 shares were attributable to his participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

Sherwin-Williams President, Consumer Brands Group Todd D. Rea reported equity award activity in company stock. He acquired 5,100 shares of Common Stock on a grant/award basis at a stated price of $0.0000 per share, reflecting the payout of a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 and tied to performance conditions for the 2023–2025 period.

To cover related tax withholding obligations upon vesting of this PRSU award, 1,883 shares of Common Stock were disposed of at $368.5900 per share through a tax-withholding disposition, rather than an open-market sale. Following these transactions, he directly held 12,546 shares of Common Stock. Separately, 5,407.03 shares are attributable to his participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

The Sherwin-Williams Company President & CEO Heidi G. Petz reported equity compensation changes involving the company’s common stock. On February 17, 2026, she acquired 16,800 shares of common stock at $0.00 per share as a vested performance-based restricted stock unit (PRSU) award for the 2023–2025 performance period under the company’s equity and performance incentive plan. On the same date, 7,494 shares of common stock were disposed of at $368.5900 per share, representing shares mandatorily withheld by the company to cover tax withholding obligations triggered by the PRSU vesting. Following these transactions, she directly owned 26,468 shares of common stock and indirectly held 376.7800 shares through participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

Sherwin-Williams SVP Finance and CFO Benjamin E. Meisenzahl reported equity compensation activity in company common stock. He acquired 960 shares at $0.00 per share as a vested performance-based restricted stock unit award covering the 2023–2025 period. To cover taxes on this vesting, 296 shares were mandatorily withheld at $368.59 per share rather than sold on the open market. After these transactions, he directly holds 6,337.4 shares of common stock and has an additional 257.12 shares through The Sherwin-Williams Company 401(k) Plan per the trustee’s 2/13/2026 statement.

Rhea-AI Summary

The Sherwin-Williams Company senior vice president James P. Lang reported equity compensation activity in company stock. On the reported date, he acquired 714 shares of common stock through the vesting and payout of a performance-based restricted stock unit award, at no cash price. In connection with this vesting, 230 shares were mandatorily withheld by the company at $368.59 per share to cover related tax obligations, a non–open-market disposition. Following these transactions, he directly holds 861 shares of common stock and has an additional 1,038.56 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

The Sherwin-Williams Company president of Global Industrial, Karl J. Jorgenrud, reported equity compensation activity involving common stock. On February 17, 2026, a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 for the 2023–2025 performance period vested and paid out in 9,600 shares of common stock, recorded as an acquisition at $0.00 per share.

The company mandatorily withheld 4,379 shares at $368.59 per share to cover Jorgenrud’s tax liabilities upon vesting, reported as a tax-withholding disposition rather than an open-market sale. After these transactions, he directly held 19,739.84 shares of common stock and had an additional 1,180.08 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan, based on the plan trustee’s February 13, 2026 statement.

Rhea-AI Summary

The Sherwin-Williams Company senior vice president James R. Jaye reported equity compensation activity involving common stock. On February 17, 2026, a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 vested for the 2023–2025 performance period, resulting in an acquisition of 2,100 shares of common stock at no cost under the company’s 2006 Equity and Performance Incentive Plan.

To cover tax withholding liabilities from this vesting, 639 shares of common stock were mandatorily withheld by Sherwin-Williams at $368.59 per share, reducing directly held shares to 5,536.57. In addition, 147.68 shares are attributed to Jaye’s participation in the Sherwin-Williams 401(k) Plan, and his reported direct holdings include 36.35 shares acquired through dividend reinvestment.

Rhea-AI Summary

Sherwin-Williams senior vice president and chief legal officer Mary L. Garceau reported equity compensation activity in company common stock. She acquired 9,000 shares at a stated price of $0.0000 through a performance-based restricted stock unit award that vested based on 2023–2025 performance conditions. On the same date, 3,618 shares at $368.5900 per share were withheld by the company to cover her tax obligations from this vesting, meaning these were not open-market sales. Following these transactions, she directly held 35,357 shares of common stock and indirectly held 901.97 shares through The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

The Sherwin-Williams Company executive Colin M. Davie reported equity compensation activity involving company common stock. He acquired 3,300 shares on a grant or award basis at $0.0000 per share, tied to a performance-based restricted stock unit (PRSU) award that vested for the 2023–2025 performance period.

To cover related tax withholding obligations upon this PRSU vesting, 1,346 shares were disposed of at $368.5900 per share through a tax-withholding transaction, rather than an open-market sale. After these transactions, he directly owned 7,319 common shares, and an additional 563.36 shares were held indirectly through The Sherwin-Williams Company 401(k) Plan as of the trustee’s 2/13/2026 statement.

Rhea-AI Summary

Sherwin-Williams Company senior vice president and CHRO Marlena K. Boyce reported equity compensation activity in company stock. On February 17, 2026, she acquired 1,338 shares of common stock at $0.00 per share from a performance-based restricted stock unit (PRSU) award granted on February 14, 2023 for the 2023–2025 performance period. To cover tax withholding on this vesting, 411 shares were mandatorily surrendered back to the company at $368.59 per share, a tax-withholding disposition rather than an open-market sale. After these transactions, she directly owned 1,285 shares of Sherwin-Williams common stock.

Rhea-AI Summary

Sherwin-Williams executive Justin T. Binns reported equity compensation activity involving common stock. He acquired 9,900 shares through the vesting and payout of a performance-based restricted stock unit (PRSU) award covering the 2023–2025 performance period, granted under the company’s equity and performance incentive plan.

To cover tax withholding on this vesting, 4,416 shares were mandatorily withheld by the company at a price of $368.59 per share, a non-open-market, tax-withholding disposition. After these transactions, he directly holds 21,937 common shares and has an additional 5,922.35 shares attributable to his participation in The Sherwin-Williams Company 401(k) Plan.

Rhea-AI Summary

Director Thomas Williams reported an acquisition of 558 shares of Sherwin-Williams common stock on a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. Each RSU equals one share of common stock and vests in three annual installments starting February 16, 2027.

After this award, Williams holds 2,371 shares of Sherwin-Williams common stock directly and 1,053.14 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, which also accumulates units via a dividend reinvestment feature.

Rhea-AI Summary

Sherwin-Williams director Aaron Powell reported an equity award tied to 558 shares of Common Stock on February 17, 2026. The filing classifies this as an acquisition granted at a price of $0.00 per share under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan.

The award is in the form of restricted stock units, each representing the right to receive one share of Common Stock. These RSUs vest annually in three substantially equal installments starting on February 16, 2027. After this grant, Powell beneficially owns 3,587 shares in total, consisting of 1,100 RSUs and 2,487 shares of Common Stock held directly.

Rhea-AI Summary

The Sherwin-Williams Company director Matthew Thornton III received an equity award in the form of restricted stock units that convert into common stock. On February 17, 2026, he acquired 558 shares of common stock at a price of $0 per share as part of this grant.

The award was made under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. The restricted stock units vest in three substantially equal annual installments starting on February 16, 2027. Following this transaction, he beneficially owned 12,854 common shares, including 1,100 RSUs and 11,754 shares of common stock.

Rhea-AI Summary

THAMAN MICHAEL H reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Michael H. Thaman reported an award of 558 restricted stock units, each representing one share of Common Stock, granted at $0 under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three annual installments starting on February 16, 2027. After this grant, he beneficially owns 8,111 shares and RSUs directly and 5,480.97 deferred stock units indirectly through the 2005 Director Deferred Fee Plan.

Rhea-AI Summary

STEWART MARTA R reported acquisition or exercise transactions in a Form 4 filing for SHW. The filing lists transactions totaling 558 shares. Following the reported transactions, holdings were 3,484 shares.

Rhea-AI Summary

Gamgort Robert James reported acquisition or exercise transactions in this Form 4 filing.

Sherwin-Williams director Robert James Gamgort reported receiving a grant of 558 restricted stock units (RSUs) of Common Stock on February 17, 2026 at a reported price of $0 per share under the 2025 Equity and Incentive Compensation Plan. Each RSU represents one share of Sherwin-Williams common stock and will vest in three substantially equal annual installments starting on February 16, 2027. After this grant, Gamgort beneficially owns 1,075 RSUs directly, and separately holds 380.04 deferred stock units indirectly through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.

Rhea-AI Summary

Sherwin-Williams director Jeff M. Fettig reported an equity award from the company. On February 17, 2026, he acquired 558 shares of Common Stock at $0 as part of a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three substantially equal annual installments starting February 16, 2027. After this award, he beneficially owns 7,019 shares, consisting of 1,100 RSUs and 5,919 shares of Common Stock.

Rhea-AI Summary

The Sherwin-Williams Company director Kerrii B. Anderson received an equity grant in the form of restricted stock units. On February 17, 2026, Anderson was awarded 558 shares of Sherwin-Williams common stock at a price of $0, as a grant, award, or other acquisition under the company’s 2025 Equity and Incentive Compensation Plan.

After this grant, Anderson directly beneficially owned 5,819 common shares, which the filing notes consist of 1,100 restricted stock units and 4,719 shares of common stock. In addition, Anderson indirectly held 1,010.94 deferred stock units through the 2005 Director Deferred Fee Plan, including units accumulated via dividend reinvestment.

Rhea-AI Summary

The Sherwin-Williams Company executive reports a routine tax-related share disposition. President, Global Architectural Justin T. Binns had 1,469 shares of common stock mandatorily withheld at $372.49 per share on February 13, 2026 to cover tax obligations upon vesting of 4,175 restricted stock units granted in 2023.

After this tax-withholding disposition, he directly beneficially owns 16,453 common shares and indirectly holds 5,922.35 shares through The Sherwin-Williams Company 401(k) Plan. The filing reflects compensation-related equity activity rather than an open-market trade.